nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—ABCB1—Vismodegib—skin cancer	0.126	0.182	CbGbCtD
Reboxetine—CYP3A4—Imiquimod—skin cancer	0.109	0.157	CbGbCtD
Reboxetine—CYP3A4—Temozolomide—skin cancer	0.109	0.157	CbGbCtD
Reboxetine—CYP2D6—Vemurafenib—skin cancer	0.094	0.135	CbGbCtD
Reboxetine—CYP3A4—Vismodegib—skin cancer	0.0756	0.109	CbGbCtD
Reboxetine—ABCB1—Dactinomycin—skin cancer	0.0663	0.0954	CbGbCtD
Reboxetine—CYP3A4—Vemurafenib—skin cancer	0.0597	0.086	CbGbCtD
Reboxetine—ABCB1—Docetaxel—skin cancer	0.0342	0.0493	CbGbCtD
Reboxetine—CYP3A4—Docetaxel—skin cancer	0.0205	0.0295	CbGbCtD
Reboxetine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000737	0.00242	CcSEcCtD
Reboxetine—Constipation—Vemurafenib—skin cancer	0.00073	0.00239	CcSEcCtD
Reboxetine—Infection—Imiquimod—skin cancer	0.000723	0.00237	CcSEcCtD
Reboxetine—Muscular weakness—Fluorouracil—skin cancer	0.000721	0.00237	CcSEcCtD
Reboxetine—Dysuria—Temozolomide—skin cancer	0.000717	0.00235	CcSEcCtD
Reboxetine—Shock—Imiquimod—skin cancer	0.000716	0.00235	CcSEcCtD
Reboxetine—Nervous system disorder—Imiquimod—skin cancer	0.000714	0.00234	CcSEcCtD
Reboxetine—Tachycardia—Imiquimod—skin cancer	0.00071	0.00233	CcSEcCtD
Reboxetine—Pollakiuria—Temozolomide—skin cancer	0.000709	0.00232	CcSEcCtD
Reboxetine—Skin disorder—Imiquimod—skin cancer	0.000707	0.00232	CcSEcCtD
Reboxetine—Erectile dysfunction—Temozolomide—skin cancer	0.000707	0.00232	CcSEcCtD
Reboxetine—Hyperhidrosis—Imiquimod—skin cancer	0.000704	0.00231	CcSEcCtD
Reboxetine—Weight decreased—Temozolomide—skin cancer	0.000694	0.00228	CcSEcCtD
Reboxetine—Anorexia—Imiquimod—skin cancer	0.000694	0.00228	CcSEcCtD
Reboxetine—Hyperglycaemia—Temozolomide—skin cancer	0.000692	0.00227	CcSEcCtD
Reboxetine—Infestation NOS—Temozolomide—skin cancer	0.000684	0.00224	CcSEcCtD
Reboxetine—Infestation—Temozolomide—skin cancer	0.000684	0.00224	CcSEcCtD
Reboxetine—Body temperature increased—Vemurafenib—skin cancer	0.000675	0.00221	CcSEcCtD
Reboxetine—Pharyngitis—Dactinomycin—skin cancer	0.000674	0.00221	CcSEcCtD
Reboxetine—Urinary tract infection—Temozolomide—skin cancer	0.000665	0.00218	CcSEcCtD
Reboxetine—Insomnia—Imiquimod—skin cancer	0.000658	0.00216	CcSEcCtD
Reboxetine—Paraesthesia—Imiquimod—skin cancer	0.000654	0.00214	CcSEcCtD
Reboxetine—Chills—Bleomycin—skin cancer	0.000653	0.00214	CcSEcCtD
Reboxetine—Dyspnoea—Imiquimod—skin cancer	0.000649	0.00213	CcSEcCtD
Reboxetine—Somnolence—Imiquimod—skin cancer	0.000647	0.00212	CcSEcCtD
Reboxetine—Sinusitis—Temozolomide—skin cancer	0.000642	0.0021	CcSEcCtD
Reboxetine—Dyspepsia—Imiquimod—skin cancer	0.000641	0.0021	CcSEcCtD
Reboxetine—Decreased appetite—Imiquimod—skin cancer	0.000633	0.00208	CcSEcCtD
Reboxetine—Infestation NOS—Fluorouracil—skin cancer	0.00063	0.00207	CcSEcCtD
Reboxetine—Infestation—Fluorouracil—skin cancer	0.00063	0.00207	CcSEcCtD
Reboxetine—Hypersensitivity—Vemurafenib—skin cancer	0.000629	0.00206	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Imiquimod—skin cancer	0.000628	0.00206	CcSEcCtD
Reboxetine—Urinary tract infection—Fluorouracil—skin cancer	0.000613	0.00201	CcSEcCtD
Reboxetine—Conjunctivitis—Fluorouracil—skin cancer	0.000613	0.00201	CcSEcCtD
Reboxetine—Asthenia—Vemurafenib—skin cancer	0.000612	0.00201	CcSEcCtD
Reboxetine—Hallucination—Temozolomide—skin cancer	0.000611	0.002	CcSEcCtD
Reboxetine—Pharyngitis—Temozolomide—skin cancer	0.000609	0.002	CcSEcCtD
Reboxetine—Chills—Dactinomycin—skin cancer	0.000609	0.002	CcSEcCtD
Reboxetine—Urinary tract disorder—Temozolomide—skin cancer	0.000606	0.00199	CcSEcCtD
Reboxetine—Connective tissue disorder—Temozolomide—skin cancer	0.000603	0.00198	CcSEcCtD
Reboxetine—Urethral disorder—Temozolomide—skin cancer	0.000602	0.00197	CcSEcCtD
Reboxetine—Feeling abnormal—Imiquimod—skin cancer	0.0006	0.00197	CcSEcCtD
Reboxetine—Gastrointestinal pain—Imiquimod—skin cancer	0.000595	0.00195	CcSEcCtD
Reboxetine—Epistaxis—Fluorouracil—skin cancer	0.000594	0.00195	CcSEcCtD
Reboxetine—Hyponatraemia—Docetaxel—skin cancer	0.000593	0.00194	CcSEcCtD
Reboxetine—Visual impairment—Temozolomide—skin cancer	0.000592	0.00194	CcSEcCtD
Reboxetine—Sinusitis—Fluorouracil—skin cancer	0.000591	0.00194	CcSEcCtD
Reboxetine—Ill-defined disorder—Bleomycin—skin cancer	0.000588	0.00193	CcSEcCtD
Reboxetine—Anaemia—Bleomycin—skin cancer	0.000586	0.00192	CcSEcCtD
Reboxetine—Diarrhoea—Vemurafenib—skin cancer	0.000584	0.00192	CcSEcCtD
Reboxetine—Urticaria—Imiquimod—skin cancer	0.000578	0.0019	CcSEcCtD
Reboxetine—Abdominal pain—Imiquimod—skin cancer	0.000575	0.00189	CcSEcCtD
Reboxetine—Body temperature increased—Imiquimod—skin cancer	0.000575	0.00189	CcSEcCtD
Reboxetine—Eye disorder—Temozolomide—skin cancer	0.000574	0.00188	CcSEcCtD
Reboxetine—Tinnitus—Temozolomide—skin cancer	0.000572	0.00188	CcSEcCtD
Reboxetine—Malaise—Bleomycin—skin cancer	0.000571	0.00187	CcSEcCtD
Reboxetine—Cardiac disorder—Temozolomide—skin cancer	0.00057	0.00187	CcSEcCtD
Reboxetine—Leukopenia—Bleomycin—skin cancer	0.000567	0.00186	CcSEcCtD
Reboxetine—Rhinitis—Fluorouracil—skin cancer	0.000567	0.00186	CcSEcCtD
Reboxetine—Dizziness—Vemurafenib—skin cancer	0.000564	0.00185	CcSEcCtD
Reboxetine—Pharyngitis—Fluorouracil—skin cancer	0.000561	0.00184	CcSEcCtD
Reboxetine—Angiopathy—Temozolomide—skin cancer	0.000557	0.00183	CcSEcCtD
Reboxetine—Orphenadrine—SCN10A—skin cancer	0.000557	1	CrCbGaD
Reboxetine—Immune system disorder—Temozolomide—skin cancer	0.000555	0.00182	CcSEcCtD
Reboxetine—Mediastinal disorder—Temozolomide—skin cancer	0.000553	0.00181	CcSEcCtD
Reboxetine—Chills—Temozolomide—skin cancer	0.000551	0.00181	CcSEcCtD
Reboxetine—Dehydration—Docetaxel—skin cancer	0.000549	0.0018	CcSEcCtD
Reboxetine—Ill-defined disorder—Dactinomycin—skin cancer	0.000548	0.0018	CcSEcCtD
Reboxetine—Anaemia—Dactinomycin—skin cancer	0.000546	0.00179	CcSEcCtD
Reboxetine—Liver function test abnormal—Docetaxel—skin cancer	0.000545	0.00179	CcSEcCtD
Reboxetine—Vomiting—Vemurafenib—skin cancer	0.000543	0.00178	CcSEcCtD
Reboxetine—Chest pain—Bleomycin—skin cancer	0.000539	0.00177	CcSEcCtD
Reboxetine—Orthostatic hypotension—Docetaxel—skin cancer	0.000539	0.00177	CcSEcCtD
Reboxetine—Rash—Vemurafenib—skin cancer	0.000538	0.00177	CcSEcCtD
Reboxetine—Mental disorder—Temozolomide—skin cancer	0.000538	0.00176	CcSEcCtD
Reboxetine—Dermatitis—Vemurafenib—skin cancer	0.000538	0.00176	CcSEcCtD
Reboxetine—Hypersensitivity—Imiquimod—skin cancer	0.000536	0.00176	CcSEcCtD
Reboxetine—Headache—Vemurafenib—skin cancer	0.000535	0.00175	CcSEcCtD
Reboxetine—Malnutrition—Temozolomide—skin cancer	0.000535	0.00175	CcSEcCtD
Reboxetine—Breast disorder—Docetaxel—skin cancer	0.000533	0.00175	CcSEcCtD
Reboxetine—Discomfort—Bleomycin—skin cancer	0.000533	0.00175	CcSEcCtD
Reboxetine—Malaise—Dactinomycin—skin cancer	0.000533	0.00175	CcSEcCtD
Reboxetine—Leukopenia—Dactinomycin—skin cancer	0.000529	0.00173	CcSEcCtD
Reboxetine—Dysgeusia—Temozolomide—skin cancer	0.000523	0.00172	CcSEcCtD
Reboxetine—Asthenia—Imiquimod—skin cancer	0.000522	0.00171	CcSEcCtD
Reboxetine—Confusional state—Bleomycin—skin cancer	0.000521	0.00171	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000521	0.00171	CcSEcCtD
Reboxetine—Infection—Bleomycin—skin cancer	0.000514	0.00168	CcSEcCtD
Reboxetine—Nausea—Vemurafenib—skin cancer	0.000507	0.00166	CcSEcCtD
Reboxetine—Tremor—Temozolomide—skin cancer	0.000501	0.00164	CcSEcCtD
Reboxetine—Diarrhoea—Imiquimod—skin cancer	0.000498	0.00163	CcSEcCtD
Reboxetine—Discomfort—Dactinomycin—skin cancer	0.000497	0.00163	CcSEcCtD
Reboxetine—Ill-defined disorder—Temozolomide—skin cancer	0.000496	0.00163	CcSEcCtD
Reboxetine—Anaemia—Temozolomide—skin cancer	0.000494	0.00162	CcSEcCtD
Reboxetine—Anorexia—Bleomycin—skin cancer	0.000493	0.00162	CcSEcCtD
Reboxetine—Agitation—Temozolomide—skin cancer	0.000491	0.00161	CcSEcCtD
Reboxetine—Hypotension—Bleomycin—skin cancer	0.000483	0.00158	CcSEcCtD
Reboxetine—Malaise—Temozolomide—skin cancer	0.000482	0.00158	CcSEcCtD
Reboxetine—Dizziness—Imiquimod—skin cancer	0.000481	0.00158	CcSEcCtD
Reboxetine—Vertigo—Temozolomide—skin cancer	0.00048	0.00157	CcSEcCtD
Reboxetine—Infection—Dactinomycin—skin cancer	0.000479	0.00157	CcSEcCtD
Reboxetine—Leukopenia—Temozolomide—skin cancer	0.000478	0.00157	CcSEcCtD
Reboxetine—Palpitations—Temozolomide—skin cancer	0.000472	0.00155	CcSEcCtD
Reboxetine—Paraesthesia—Bleomycin—skin cancer	0.000464	0.00152	CcSEcCtD
Reboxetine—Vomiting—Imiquimod—skin cancer	0.000463	0.00152	CcSEcCtD
Reboxetine—Weight decreased—Docetaxel—skin cancer	0.000462	0.00151	CcSEcCtD
Reboxetine—Hypertension—Temozolomide—skin cancer	0.000461	0.00151	CcSEcCtD
Reboxetine—Dyspnoea—Bleomycin—skin cancer	0.000461	0.00151	CcSEcCtD
Reboxetine—Anorexia—Dactinomycin—skin cancer	0.00046	0.00151	CcSEcCtD
Reboxetine—Rash—Imiquimod—skin cancer	0.000459	0.00151	CcSEcCtD
Reboxetine—Dermatitis—Imiquimod—skin cancer	0.000459	0.0015	CcSEcCtD
Reboxetine—Headache—Imiquimod—skin cancer	0.000456	0.0015	CcSEcCtD
Reboxetine—Anaemia—Fluorouracil—skin cancer	0.000455	0.00149	CcSEcCtD
Reboxetine—Infestation—Docetaxel—skin cancer	0.000455	0.00149	CcSEcCtD
Reboxetine—Infestation NOS—Docetaxel—skin cancer	0.000455	0.00149	CcSEcCtD
Reboxetine—Anxiety—Temozolomide—skin cancer	0.000453	0.00149	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000452	0.00148	CcSEcCtD
Reboxetine—Discomfort—Temozolomide—skin cancer	0.00045	0.00147	CcSEcCtD
Reboxetine—Decreased appetite—Bleomycin—skin cancer	0.00045	0.00147	CcSEcCtD
Reboxetine—Dry mouth—Temozolomide—skin cancer	0.000445	0.00146	CcSEcCtD
Reboxetine—Conjunctivitis—Docetaxel—skin cancer	0.000442	0.00145	CcSEcCtD
Reboxetine—Leukopenia—Fluorouracil—skin cancer	0.000441	0.00145	CcSEcCtD
Reboxetine—Confusional state—Temozolomide—skin cancer	0.00044	0.00144	CcSEcCtD
Reboxetine—Infection—Temozolomide—skin cancer	0.000433	0.00142	CcSEcCtD
Reboxetine—Nausea—Imiquimod—skin cancer	0.000432	0.00142	CcSEcCtD
Reboxetine—Epistaxis—Docetaxel—skin cancer	0.000429	0.00141	CcSEcCtD
Reboxetine—Nervous system disorder—Temozolomide—skin cancer	0.000428	0.0014	CcSEcCtD
Reboxetine—Feeling abnormal—Bleomycin—skin cancer	0.000426	0.0014	CcSEcCtD
Reboxetine—Skin disorder—Temozolomide—skin cancer	0.000424	0.00139	CcSEcCtD
Reboxetine—Hyperhidrosis—Temozolomide—skin cancer	0.000422	0.00138	CcSEcCtD
Reboxetine—Chest pain—Fluorouracil—skin cancer	0.000419	0.00138	CcSEcCtD
Reboxetine—Decreased appetite—Dactinomycin—skin cancer	0.000419	0.00138	CcSEcCtD
Reboxetine—Anorexia—Temozolomide—skin cancer	0.000416	0.00136	CcSEcCtD
Reboxetine—Discomfort—Fluorouracil—skin cancer	0.000414	0.00136	CcSEcCtD
Reboxetine—Urticaria—Bleomycin—skin cancer	0.000411	0.00135	CcSEcCtD
Reboxetine—Rhinitis—Docetaxel—skin cancer	0.000409	0.00134	CcSEcCtD
Reboxetine—Body temperature increased—Bleomycin—skin cancer	0.000409	0.00134	CcSEcCtD
Reboxetine—Confusional state—Fluorouracil—skin cancer	0.000405	0.00133	CcSEcCtD
Reboxetine—Pharyngitis—Docetaxel—skin cancer	0.000405	0.00133	CcSEcCtD
Reboxetine—Urinary tract disorder—Docetaxel—skin cancer	0.000403	0.00132	CcSEcCtD
Reboxetine—Connective tissue disorder—Docetaxel—skin cancer	0.000401	0.00132	CcSEcCtD
Reboxetine—Urethral disorder—Docetaxel—skin cancer	0.0004	0.00131	CcSEcCtD
Reboxetine—Infection—Fluorouracil—skin cancer	0.000399	0.00131	CcSEcCtD
Reboxetine—Feeling abnormal—Dactinomycin—skin cancer	0.000397	0.0013	CcSEcCtD
Reboxetine—Insomnia—Temozolomide—skin cancer	0.000395	0.00129	CcSEcCtD
Reboxetine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000394	0.00129	CcSEcCtD
Reboxetine—Nervous system disorder—Fluorouracil—skin cancer	0.000394	0.00129	CcSEcCtD
Reboxetine—Visual impairment—Docetaxel—skin cancer	0.000394	0.00129	CcSEcCtD
Reboxetine—Tachycardia—Fluorouracil—skin cancer	0.000392	0.00129	CcSEcCtD
Reboxetine—Paraesthesia—Temozolomide—skin cancer	0.000392	0.00128	CcSEcCtD
Reboxetine—Dyspnoea—Temozolomide—skin cancer	0.000389	0.00128	CcSEcCtD
Reboxetine—Somnolence—Temozolomide—skin cancer	0.000388	0.00127	CcSEcCtD
Reboxetine—Dyspepsia—Temozolomide—skin cancer	0.000384	0.00126	CcSEcCtD
Reboxetine—Anorexia—Fluorouracil—skin cancer	0.000383	0.00126	CcSEcCtD
Reboxetine—Eye disorder—Docetaxel—skin cancer	0.000382	0.00125	CcSEcCtD
Reboxetine—Body temperature increased—Dactinomycin—skin cancer	0.000381	0.00125	CcSEcCtD
Reboxetine—Abdominal pain—Dactinomycin—skin cancer	0.000381	0.00125	CcSEcCtD
Reboxetine—Hypersensitivity—Bleomycin—skin cancer	0.000381	0.00125	CcSEcCtD
Reboxetine—Decreased appetite—Temozolomide—skin cancer	0.000379	0.00124	CcSEcCtD
Reboxetine—Cardiac disorder—Docetaxel—skin cancer	0.000379	0.00124	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000377	0.00124	CcSEcCtD
Reboxetine—Hypotension—Fluorouracil—skin cancer	0.000376	0.00123	CcSEcCtD
Reboxetine—Constipation—Temozolomide—skin cancer	0.000373	0.00122	CcSEcCtD
Reboxetine—Asthenia—Bleomycin—skin cancer	0.000371	0.00122	CcSEcCtD
Reboxetine—Angiopathy—Docetaxel—skin cancer	0.00037	0.00122	CcSEcCtD
Reboxetine—Immune system disorder—Docetaxel—skin cancer	0.000369	0.00121	CcSEcCtD
Reboxetine—Mediastinal disorder—Docetaxel—skin cancer	0.000368	0.00121	CcSEcCtD
Reboxetine—Chills—Docetaxel—skin cancer	0.000366	0.0012	CcSEcCtD
Reboxetine—Insomnia—Fluorouracil—skin cancer	0.000364	0.00119	CcSEcCtD
Reboxetine—Paraesthesia—Fluorouracil—skin cancer	0.000361	0.00118	CcSEcCtD
Reboxetine—Feeling abnormal—Temozolomide—skin cancer	0.000359	0.00118	CcSEcCtD
Reboxetine—Dyspnoea—Fluorouracil—skin cancer	0.000358	0.00118	CcSEcCtD
Reboxetine—Mental disorder—Docetaxel—skin cancer	0.000358	0.00117	CcSEcCtD
Reboxetine—Somnolence—Fluorouracil—skin cancer	0.000357	0.00117	CcSEcCtD
Reboxetine—Gastrointestinal pain—Temozolomide—skin cancer	0.000357	0.00117	CcSEcCtD
Reboxetine—Malnutrition—Docetaxel—skin cancer	0.000355	0.00117	CcSEcCtD
Reboxetine—Hypersensitivity—Dactinomycin—skin cancer	0.000355	0.00117	CcSEcCtD
Reboxetine—Dyspepsia—Fluorouracil—skin cancer	0.000354	0.00116	CcSEcCtD
Reboxetine—Decreased appetite—Fluorouracil—skin cancer	0.000349	0.00115	CcSEcCtD
Reboxetine—Dysgeusia—Docetaxel—skin cancer	0.000348	0.00114	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000347	0.00114	CcSEcCtD
Reboxetine—Urticaria—Temozolomide—skin cancer	0.000347	0.00114	CcSEcCtD
Reboxetine—Asthenia—Dactinomycin—skin cancer	0.000346	0.00113	CcSEcCtD
Reboxetine—Abdominal pain—Temozolomide—skin cancer	0.000345	0.00113	CcSEcCtD
Reboxetine—Body temperature increased—Temozolomide—skin cancer	0.000345	0.00113	CcSEcCtD
Reboxetine—Feeling abnormal—Fluorouracil—skin cancer	0.000331	0.00109	CcSEcCtD
Reboxetine—Diarrhoea—Dactinomycin—skin cancer	0.00033	0.00108	CcSEcCtD
Reboxetine—Vomiting—Bleomycin—skin cancer	0.000329	0.00108	CcSEcCtD
Reboxetine—Anaemia—Docetaxel—skin cancer	0.000329	0.00108	CcSEcCtD
Reboxetine—Rash—Bleomycin—skin cancer	0.000326	0.00107	CcSEcCtD
Reboxetine—Dermatitis—Bleomycin—skin cancer	0.000326	0.00107	CcSEcCtD
Reboxetine—Hypersensitivity—Temozolomide—skin cancer	0.000321	0.00105	CcSEcCtD
Reboxetine—Urticaria—Fluorouracil—skin cancer	0.000319	0.00105	CcSEcCtD
Reboxetine—Syncope—Docetaxel—skin cancer	0.000319	0.00105	CcSEcCtD
Reboxetine—Leukopenia—Docetaxel—skin cancer	0.000318	0.00104	CcSEcCtD
Reboxetine—Body temperature increased—Fluorouracil—skin cancer	0.000318	0.00104	CcSEcCtD
Reboxetine—Palpitations—Docetaxel—skin cancer	0.000314	0.00103	CcSEcCtD
Reboxetine—Asthenia—Temozolomide—skin cancer	0.000313	0.00103	CcSEcCtD
Reboxetine—Loss of consciousness—Docetaxel—skin cancer	0.000312	0.00102	CcSEcCtD
Reboxetine—Nausea—Bleomycin—skin cancer	0.000307	0.00101	CcSEcCtD
Reboxetine—Hypertension—Docetaxel—skin cancer	0.000307	0.00101	CcSEcCtD
Reboxetine—Vomiting—Dactinomycin—skin cancer	0.000307	0.00101	CcSEcCtD
Reboxetine—Rash—Dactinomycin—skin cancer	0.000304	0.000997	CcSEcCtD
Reboxetine—Chest pain—Docetaxel—skin cancer	0.000303	0.000992	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000301	0.000986	CcSEcCtD
Reboxetine—Diarrhoea—Temozolomide—skin cancer	0.000298	0.000979	CcSEcCtD
Reboxetine—Hypersensitivity—Fluorouracil—skin cancer	0.000296	0.000971	CcSEcCtD
Reboxetine—Dry mouth—Docetaxel—skin cancer	0.000296	0.000971	CcSEcCtD
Reboxetine—Confusional state—Docetaxel—skin cancer	0.000293	0.000959	CcSEcCtD
Reboxetine—Dizziness—Temozolomide—skin cancer	0.000288	0.000946	CcSEcCtD
Reboxetine—Infection—Docetaxel—skin cancer	0.000288	0.000945	CcSEcCtD
Reboxetine—Nausea—Dactinomycin—skin cancer	0.000286	0.00094	CcSEcCtD
Reboxetine—Shock—Docetaxel—skin cancer	0.000285	0.000936	CcSEcCtD
Reboxetine—Nervous system disorder—Docetaxel—skin cancer	0.000284	0.000933	CcSEcCtD
Reboxetine—Tachycardia—Docetaxel—skin cancer	0.000283	0.000929	CcSEcCtD
Reboxetine—Skin disorder—Docetaxel—skin cancer	0.000282	0.000924	CcSEcCtD
Reboxetine—Vomiting—Temozolomide—skin cancer	0.000277	0.00091	CcSEcCtD
Reboxetine—Anorexia—Docetaxel—skin cancer	0.000277	0.000907	CcSEcCtD
Reboxetine—Rash—Temozolomide—skin cancer	0.000275	0.000902	CcSEcCtD
Reboxetine—Diarrhoea—Fluorouracil—skin cancer	0.000275	0.000902	CcSEcCtD
Reboxetine—Dermatitis—Temozolomide—skin cancer	0.000275	0.000901	CcSEcCtD
Reboxetine—Headache—Temozolomide—skin cancer	0.000273	0.000896	CcSEcCtD
Reboxetine—Hypotension—Docetaxel—skin cancer	0.000271	0.000889	CcSEcCtD
Reboxetine—Dizziness—Fluorouracil—skin cancer	0.000266	0.000872	CcSEcCtD
Reboxetine—Insomnia—Docetaxel—skin cancer	0.000262	0.000861	CcSEcCtD
Reboxetine—Paraesthesia—Docetaxel—skin cancer	0.00026	0.000854	CcSEcCtD
Reboxetine—Nausea—Temozolomide—skin cancer	0.000259	0.00085	CcSEcCtD
Reboxetine—Dyspnoea—Docetaxel—skin cancer	0.000259	0.000848	CcSEcCtD
Reboxetine—Somnolence—Docetaxel—skin cancer	0.000258	0.000846	CcSEcCtD
Reboxetine—Vomiting—Fluorouracil—skin cancer	0.000256	0.000838	CcSEcCtD
Reboxetine—Dyspepsia—Docetaxel—skin cancer	0.000255	0.000837	CcSEcCtD
Reboxetine—Rash—Fluorouracil—skin cancer	0.000253	0.000831	CcSEcCtD
Reboxetine—Dermatitis—Fluorouracil—skin cancer	0.000253	0.00083	CcSEcCtD
Reboxetine—Decreased appetite—Docetaxel—skin cancer	0.000252	0.000827	CcSEcCtD
Reboxetine—Headache—Fluorouracil—skin cancer	0.000252	0.000826	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Docetaxel—skin cancer	0.00025	0.000821	CcSEcCtD
Reboxetine—Constipation—Docetaxel—skin cancer	0.000248	0.000814	CcSEcCtD
Reboxetine—Feeling abnormal—Docetaxel—skin cancer	0.000239	0.000784	CcSEcCtD
Reboxetine—Nausea—Fluorouracil—skin cancer	0.000239	0.000783	CcSEcCtD
Reboxetine—Gastrointestinal pain—Docetaxel—skin cancer	0.000237	0.000778	CcSEcCtD
Reboxetine—Abdominal pain—Docetaxel—skin cancer	0.000229	0.000752	CcSEcCtD
Reboxetine—Body temperature increased—Docetaxel—skin cancer	0.000229	0.000752	CcSEcCtD
Reboxetine—Hypersensitivity—Docetaxel—skin cancer	0.000214	0.000701	CcSEcCtD
Reboxetine—Asthenia—Docetaxel—skin cancer	0.000208	0.000683	CcSEcCtD
Reboxetine—Diarrhoea—Docetaxel—skin cancer	0.000198	0.000651	CcSEcCtD
Reboxetine—Dizziness—Docetaxel—skin cancer	0.000192	0.000629	CcSEcCtD
Reboxetine—Vomiting—Docetaxel—skin cancer	0.000184	0.000605	CcSEcCtD
Reboxetine—Rash—Docetaxel—skin cancer	0.000183	0.0006	CcSEcCtD
Reboxetine—Dermatitis—Docetaxel—skin cancer	0.000183	0.000599	CcSEcCtD
Reboxetine—Headache—Docetaxel—skin cancer	0.000182	0.000596	CcSEcCtD
Reboxetine—Nausea—Docetaxel—skin cancer	0.000172	0.000565	CcSEcCtD
